Santiago de Compostela, Spain

Marcos Eugenio Vázquez Sentís


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Marcos Eugenio Vázquez Sentís in Cancer Treatment

Introduction

Marcos Eugenio Vázquez Sentís is a notable inventor based in Santiago de Compostela, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the use of ruthenium complexes, which have the potential to revolutionize cancer therapies.

Latest Patents

One of his key patents is titled "Ruthenium complexes for treating cancer which comprises cancer stem cells." This invention relates to the use of ruthenium(II) complexes for preparing a medicinal product aimed at treating cancer, particularly cancers that involve cancer stem cells. The ruthenium complexes are capable of selectively metallating guanine quadruplexes, leading to an increased expression of the c-MYC oncogene. This increase may promote the differentiation of cancer stem cells, offering a new avenue for cancer treatment. He holds 1 patent in this area.

Career Highlights

Throughout his career, Vázquez Sentís has worked with prestigious institutions such as the Universidade de Santiago De Compostela and the Universidad Autónoma De Madrid. His research has garnered attention for its innovative approach to addressing complex medical challenges.

Collaborations

He has collaborated with notable colleagues, including Jessica Rodríguez Villar and José Luis Mascareñas Cid. Their joint efforts have contributed to advancing research in the field of cancer treatment.

Conclusion

Marcos Eugenio Vázquez Sentís stands out as an influential inventor in the realm of cancer research. His innovative use of ruthenium complexes presents promising possibilities for future cancer therapies. His contributions continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…